129 - Phase I Trial of GD2.CAR T Cells Combined with a Novel Interleukin-7 Signal Modulator

Autor: Omer, Bilal, Shum, Thomas, Foster, Jennifer, Parikh, Kathan, Tat, Candise, Shekar, Meghan, Vivekananthan, Annika, Mehta, Birju, Zhang, Huimin, Thakkar, Sachin G., Naik, Swati, Heslop, Helen E., Brenner, Malcolm K., Rooney, Cliona M.
Zdroj: In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S105-S106
Databáze: ScienceDirect
Externí odkaz: